Expertise in
1
conditions

Daniela S. Katz

Jerusalem, JM, IL 
Expertise in
1
conditions
Jerusalem, JM, IL 

Overview

Daniela Katz practices practicing medicine in Jerusalem, Israel.

Ms. Katz is highly rated in 1 condition, according to our data. Her clinical expertise encompasses BRCA Positive Breast Cancer, Adult Soft Tissue Sarcoma, Synovial Sarcoma, and Breast Cancer.

She is actively involved in clinical research, co-authoring 27 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Jerusalem, JM, Israel
Other Locations
Shamir, Z, Israel
Zerifin, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 24, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-label, Active-controlled, Multicenter Trial
Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-label, Active-controlled, Multicenter Trial
Enrollment Status: Completed
Publish Date: September 15, 2025
Intervention Type: Drug
Study Drugs: Elacestrant, Standard of Care
Study Phase: Phase 3
View 1 Less Clinical Trial

27 Total Publications

CBFB mutations predict endocrine therapy benefit in estrogen receptor-positive breast cancer.
CBFB mutations predict endocrine therapy benefit in estrogen receptor-positive breast cancer.
Journal: medRxiv : the preprint server for health sciences
Published: June 04, 2026

Frequently Asked Questions about Daniela S. Katz

Is Daniela S. Katz a top-rated expert for BRCA Positive Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Daniela S. Katz is classified as an Distinguished expert for BRCA Positive Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Daniela S. Katz participate in research or clinical trials?

Yes. Daniela S. Katz has published 27 articles and abstracts on conditions like BRCA Positive Breast Cancer. You can view a list of Daniela S. Katz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Katz's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile